KAWKAB SCIENTIFIC BUREAU* — Valsartan Importer Profile
Pharmaceutical Importer · #14 buyer for Valsartan · $2.3M import value · 100 shipments · IRAQ · DGFT Verified
KAWKAB SCIENTIFIC BUREAU* is the #14 importer of Valsartan from India with $2.3M in import value and 100 verified shipments. KAWKAB SCIENTIFIC BUREAU* holds a 1.2% market share in Valsartan imports based in IRAQ. The company sources from 1 verified supplier across 70 formulations shipped to 1 country. Overall, KAWKAB SCIENTIFIC BUREAU* imports 3 pharmaceutical products worth $3.9M across 3 therapeutic categories.
KAWKAB SCIENTIFIC BUREAU* — Valsartan Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Valsartan to KAWKAB SCIENTIFIC BUREAU*?
Verified from 100 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| AJANTA PHARMA LIMITED | $2.3M | 100 | 100.0% |
KAWKAB SCIENTIFIC BUREAU* sources Valsartan from 1 verified Indian supplier based on 100 customs records. The primary supplier is AJANTA PHARMA LIMITED accounting for 100.0% of imports.
How Does KAWKAB SCIENTIFIC BUREAU* Compare to Nearest Valsartan Importers?
Buyers ranked immediately above and below #14 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | DR. REDDYS LABORATORIES, INC | UNITED STATES | $3.0M | 60 | $50.0K |
| 3 | MACLEODS PHARMA USA,INC | UNITED STATES | $3.0M | 59 | $50.0K |
| 14 | KAWKAB SCIENTIFIC BUREAU* ★ | IRAQ | $2.4M | 78 | $30.9K |
| 2 | MACLEODS PHARMA USA ,INC | UNITED STATES | $2.4M | 48 | $50.0K |
| 15 | J KNIPPER COMPANY | UNITED STATES | $2.4M | 47 | $50.0K |
KAWKAB SCIENTIFIC BUREAU* ranks #14 among 663 Valsartan importers from India. Average shipment value of $30.9K compared to the market average of $71.0K. The closest competitors by value are DR. REDDYS LABORATORIES, INC and MACLEODS PHARMA USA,INC.
Where Does KAWKAB SCIENTIFIC BUREAU* Import Valsartan To?
Destination countries from 100 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| IRAQ | $2.3M | 100 | 100.0% |
KAWKAB SCIENTIFIC BUREAU* imports Valsartan to 1 country. The primary destination is IRAQ receiving 100.0% of shipments worth $2.3M.
What Valsartan Formulations Does KAWKAB SCIENTIFIC BUREAU* Import?
| Formulation | Value | Shipments |
|---|---|---|
| LASTAVIN AM PLUS 10/160/12.5[34230x3x10=1026900TABS][NET WT.OF BULK DRUG VALSARTAN USP IS 164.304KGS][AMLODIPINE, VALSAR | $150.0K | 3 |
| LASTAVIN AM PLUS 10/160/12.5[NETWT.OF BULKDRUG VALSARTAN USP:76.944KGS][16030PACX3X10=480900TAB]AMLODIPINEVALSARTAN&HYDNOS | $96.0K | 3 |
| LASTAVIN HTZ 160/12.5 MG TABS[NET WT.OFBULK DRUG VALSARTAN USP IS 117.408 KGS][24460PACX3X10=733800TABS]VALSARTAN&HYDRO | $93.7K | 3 |
| LASTAVIN AM 160/10 MG TABS[NETWT.OF BULKDRUG VALSARTAN USP:74.304KGS]15480PACx3X10=464400TABS]VALSARTAN 160MG&AMLODIPINE | $60.8K | 3 |
| LASTAVIN AM 160/10MG TABS[NETWT.OF BULKDRUG VALSARTAN USP:76.752KGS][15990PACx3X10=479700TAB]VALSARTAN160MG&AMLODIPINE10 | $50.0K | 1 |
| LASTAVIN AM PLUS 10/160/12.5 [24820x3x10=744600 TABS][NET WT.OF BULK DRUG VALSARTAN USP IS 119.136 KGS][AMLODIPINE VALS | $50.0K | 1 |
| LASTAVIN AM 160/5 MG TABS[35680 X 3 X 10= 1070400 TABLETS][NET WT.OF BULK DRUGVALSARTAN USP IS 171.264 KGS]VALSARTAN | $50.0K | 1 |
| LASTAVIN AM 160/10 MG TABS[15510x3x10=465300 TABS][NET WT.OF BULK DRUG VALSARTANUSP IS 74.448 KGS]VALSARTAN 160MG & AM | $50.0K | 1 |
| LASTAVIN AM 160/10MG TABS[NETWT.OF BULKDRUG VALSARTAN USP IS 110.376KGS]22995PACx3X10=689850TAB(VALSARTAN 160MG&AMLODIPI | $50.0K | 1 |
| LASTAVIN AM 160/5MG TABS[NETWT.OF BULKDRUG VALSARTAN USP IS 75.168KGS]15660PACx3X10=469800TAB(VALSARTAN 160MG&AMLODIPINE | $50.0K | 1 |
KAWKAB SCIENTIFIC BUREAU* imports 70 distinct Valsartan formulations from India. The top formulation is LASTAVIN AM PLUS 10/160/12.5[34230x3x10=1026900TABS][NET WT. with 3 shipments worth $150.0K.
Who Are the Top Buyers of Valsartan from India and How Much Does KAWKAB SCIENTIFIC BUREAU* Import?
India exported $47.1M worth of Valsartan through 6,098 shipments from 259 suppliers to 119 countries, serving 663 buyers globally. KAWKAB SCIENTIFIC BUREAU* imports $2.3M of this total, accounting for 1.2% of India's Valsartan exports with 100 shipments from IRAQ. This is verified from 100 customs shipment records covering 70 distinct formulations.
What Is the Average Order Value for KAWKAB SCIENTIFIC BUREAU*'s Valsartan Imports?
KAWKAB SCIENTIFIC BUREAU*'s average Valsartan order value is $23.3K per consignment, based on 100 shipments totaling $2.3M. KAWKAB SCIENTIFIC BUREAU* is based in IRAQ and ranks #14 among all Valsartan importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Valsartan to KAWKAB SCIENTIFIC BUREAU*?
KAWKAB SCIENTIFIC BUREAU* sources Valsartan from 1 verified Indian supplier: AJANTA PHARMA LIMITED ($2.3M, 100.0%). This is based on 100 customs records.
How Does KAWKAB SCIENTIFIC BUREAU* Compare to Other Valsartan Importers?
KAWKAB SCIENTIFIC BUREAU* ranks #14 among 663 Valsartan importers from India with a 1.2% market share. The top 3 importers are MYLAN PHARMACEUTICALS INC, ($4.7M), YUSEN LOGISTICS BENELUX BELGIUM ($4.5M), MYLAN HUNGARY KFT, ($4.5M). KAWKAB SCIENTIFIC BUREAU* processed 100 shipments from IRAQ.
About KAWKAB SCIENTIFIC BUREAU*
KAWKAB SCIENTIFIC BUREAU* imports 3 products worth $3.9M. Beyond Valsartan, top products include Cefixime, Vildagliptin. View the complete KAWKAB SCIENTIFIC BUREAU* profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Valsartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Valsartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: KAWKAB SCIENTIFIC BUREAU* matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as KAWKAB SCIENTIFIC BUREAU*'s capped import value divided by total capped export value for Valsartan across all Indian exporters.
- 5.Verified Records: This page is backed by 100 individual customs records matching KAWKAB SCIENTIFIC BUREAU* importing Valsartan, covering 70 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 119+ countries, 663+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Valsartan Import Data for KAWKAB SCIENTIFIC BUREAU*
Access order-level details, pricing data, supplier connections, and competitive analysis for KAWKAB SCIENTIFIC BUREAU*'s Valsartan imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
KAWKAB SCIENTIFIC BUREAU*
Full Company Profile →
3 products · $3.9M total trade · 3 categories
KAWKAB SCIENTIFIC BUREAU* × Valsartan
Verified from customs records
Company Overview
Top Products by KAWKAB SCIENTIFIC BUREAU*
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for KAWKAB SCIENTIFIC BUREAU*.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Valsartan. For current order-level data, contact TransData Nexus.